Ryszard Kole
Plus aucun poste en cours
Profil
Ryszard Kole worked as the Senior Vice President-Discovery Research at Sarepta Therapeutics, Inc. Prior to that, he was the President & Chief Scientific Officer at Ercole Biotech, Inc. He also worked as a Professor-Pharmacology Department at The University of North Carolina at Charlotte.
Kole holds a doctorate degree from the Polish Academy of Sciences.
Anciens postes connus de Ryszard Kole
| Sociétés | Poste | Fin |
|---|---|---|
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | President | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Ryszard Kole
| Polish Academy of Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
